Filter
1719
Filtered Results: 1719
Text search:
drug
formulations
Featured
Recommendations
189
New Publications
554
Language
Document type
No document type
1060
Guidelines
294
Studies & Reports
197
Manuals
67
Strategic & Response Plan
44
Training Material
21
Fact sheets
21
Situation Updates
5
Infographics
4
Brochures
2
Resource Platforms
2
App
1
Online Courses
1
Countries / Regions
India
103
Kenya
71
Uganda
53
Tanzania
43
Global
41
Malawi
37
Nepal
36
South Africa
35
Ethiopia
34
Liberia
32
Sierra Leone
29
Ghana
28
Nigeria
28
Zambia
27
Rwanda
26
Bangladesh
24
Philippines
22
Namibia
22
Zimbabwe
21
Myanmar / Burma
21
Latin America and the Carribbean
20
Western and Central Europe
19
Cambodia
17
Africa
16
Botswana
12
Lesotho
11
Senegal
11
Indonesia
10
Eswatini/ Swaziland
10
South–East Asia Region
9
Cameroon
8
Haiti
7
Congo, Democratic Republic of
7
Burkina Faso
6
Eastern Europe
6
Ukraine
5
Syria
5
Russia
5
Benin
4
Albania
4
Asia
4
Pakistan
4
Tajikistan
3
Thailand
3
Mozambique
3
Eastern Europe and Central Asia
3
Georgia
3
South Sudan
3
Madagascar
3
North Macedonia
2
Iran
2
Afghanistan
2
Guinea
2
USA
2
Middle East and North Africa
2
Western Pacific Region
2
North America
2
Gabon
2
United Kingdom
2
East and Southern Africa
2
Côte d’Ivoire / Ivory Coast
2
Argentina
2
Lebanon
2
Vietnam
2
Sri Lanka
2
Sudan
2
Libya
2
Colombia
1
Timor Leste/ East Timor
1
Australia
1
Gambia
1
Kazakhstan
1
Chile
1
Laos
1
Kyrgyzstan
1
Congo-Brazzaville
1
Niger
1
Peru
1
Malaysia
1
Morocco
1
Venezuela
1
Jordan
1
Ireland
1
Saudi Arabia
1
Paraguay
1
Turkmenistan
1
Denmark
1
France
1
Tunisia
1
Bolivia
1
Papua New Guinea
1
Brazil
1
Moldova
1
Yemen
1
Greece
1
Mali
1
Bhutan
1
Iraq
1
Authors & Publishers
Publication Years
Category
Countries
748
Clinical Guidelines
249
Public Health
79
Women & Child Health
78
Key Resources
41
Capacity Building
24
Pharmacy & Technologies
24
Toolboxes
HIV
178
TB
168
Pharmacy
111
AMR
104
Mental Health
90
NTDs
64
COVID-19
49
NCDs
28
Caregiver
27
Rapid Response
26
Ebola & Marburg
21
Refugee
16
Planetary Health
12
Disability
11
Health Financing Toolbox
8
Global Health Education
8
Specific Hazards
6
Cholera
6
Conflict
6
Natural Hazards
5
Polio
5
Malaria
4
Social Ethics
3
Zika
3
Jamieson D and Kellerman S. Journal of the International AIDS Society 2016, 19:20917 http://www.jiasociety.org/index.php/jias/article/view/20917 | http://dx.doi.org/10.7448/IAS.19.1.20917
Health care-associated infection (HCAI) places a serious disease burden and has a significant economic impact on patients and health-care systems throughout the world. Yet good hand hygiene, the simple task of cleaning hands at the right times and in the right way, can save lives. World Health O...
This progress report reflects achievements made during the first year of implementation (through December 2016), as countries have taken actions in line with new or existing national strategies. The most recent data on country progress in 2016 are based on country-reported data and country-developed...
Despite a historical association with poor tolerability, a comprehensive review on safety of antileishmanial chemotherapies is lacking. We carried out an update of a previous systematic review of all published clinical trials in visceral leishmaniasis (VL) from 1980 to 2019 to document any reported ...
This guideline for the prevention and control of chikungunya fever
(CF) is intended for use by all peripheral health workers in the Region and
is based on the strategy outlined above. This document will focus mainly
on preventing, predicting and detecting outbreaks, and after detection,
investig...
Seizures constitute the most common neurological problem in children and the majority of epilepsy has its onset in childhood. Appropriate diagnosis and management of childhood epilepsy is essential to improve quality of life in these children. Evidence-based clinical practice guidelines, modified to...
This guideline is intended to provide recommendations to applicants wishing to submit applications for the registration of medicines. It represents the Medicines Control Council’s current thinking on the safety, quality and efficacy of medicines.
WHO recommendations on adolescent health: guidelines approved by the WHO Guidelines Review Committee
This document is meant to respond to the questions:
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
■ What health interventions should the adolescent receive and when should s/he receive it?
■ What health behaviours should the adolescent practise (or not practise)?
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis...
The Adult Standard Treatment Guidelines and Essential Medicines List for Hospital Level provide a platform for transparency to enable equitable access to safe, effective, and affordable treatment options at hospital level taking into consideration the changing clinical needs of our population and th...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
As of October 2017, the global database comprised almost 30 000 records, including results from bioassays to measure phenotypic resistance, and biochemical and molecular tests for resistance mechanisms. The current report presents an overview of data on malaria vector resistance for 2010 to 2016. It...
Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors
recommended
The coronavirus disease (COVID-19) pandemic exacerbated pre-existing inequalities in the treatment and care of noncommunicable diseases (NCDs). This report examines the effect of the COVID-19 pandemic on access to NCD medicines, and the policies and strategies implemented by countries and health sys...
People younger than 20 years comprise 35% of the global population and 40% of the global population of least-developed nations. The number of children - neonates, infants, children, and adolescents up to 19 years of age - who need pediatric palliative care (PPC) each year may be as high as 21 millio...
